SeekingAlpha · Jul 20, 2026
BioGaia AB (publ) 2026 Q2 - Results - Earnings Call Presentation
2026-07-20. The following slide deck was published by BioGaia AB (publ) in conjunction with their 2026 Q2 earnings call.

OTC · BIOGY
Healthcare · Drug Manufacturers - Specialty & Generic
$12.45
Up+$0.00 (+0.00%)
Updated Oct 14, 2026, 10:04 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BIOGY
1M range · 0 trading sessions · Daily adjusted prices
BIOGY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning BIOGY.
Company
Market Activity
Research & News
BIOGY research
Company profile and research snapshot.
BIOGAIA AB S/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 20, 2026 | DNB CARNEGIE | Buy | — |
| Jul 6, 2026 | DNB CARNEGIE | Buy | — |
| Jul 5, 2026 | DNB CARNEGIE | Buy | — |
| Jun 18, 2026 | HANDELSBANKEN CAPITAL MARKETS | Buy | — |
| Jun 17, 2026 | HANDELSBANKEN CAPITAL MARKETS | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Jul 20, 2026
2026-07-20. The following slide deck was published by BioGaia AB (publ) in conjunction with their 2026 Q2 earnings call.
SeekingAlpha · Jul 17, 2026
BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call July 17, 2026 3:30 AM EDTCompany ParticipantsTheresa Agnew - CEO & PresidentAlexander Kotsinas -...
SeekingAlpha · Jun 2, 2026
SeekingAlpha · Feb 18, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BIOGY.
No results
No recent SID articles mention BIOGY.